Characterization of human respiratory syncytial virus in children with severe acute respiratory infection before and during the COVID-19 pandemic.

Molecular evolution Respiratory syncytial virus Severe acute respiratory infection Zambia

Journal

IJID regions
ISSN: 2772-7076
Titre abrégé: IJID Reg
Pays: England
ID NLM: 9918418183106676

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 11 03 2024
accepted: 13 03 2024
medline: 10 4 2024
pubmed: 10 4 2024
entrez: 10 4 2024
Statut: epublish

Résumé

Annual outbreaks of human respiratory syncytial virus (HRSV) are caused by newly introduced and locally persistent strains. During the COVID-19 pandemic, global and local circulation of HRSV significantly decreased. This study was conducted to characterize HRSV in 2018-2022 and to analyze the impact of COVID-19 on the evolution of HRSV. Combined oropharyngeal and nasopharyngeal swabs were collected from children hospitalized with severe acute respiratory infection at two hospitals in Zambia. The second hypervariable region of the attachment gene G was targeted for phylogenetic analysis. Of 3113 specimens, 504 (16.2%) were positive for HRSV, of which 131 (26.0%) and 66 (13.1%) were identified as HRSVA and HRSVB, respectively. In early 2021, an increase in HRSV was detected, caused by multiple distinct clades of HRSVA and HRSVB. Some were newly introduced, whereas others resulted from local persistence. This study provides insights into the evolution of HRSV, driven by global and local circulation. The COVID-19 pandemic had a temporal impact on the evolution pattern of HRSV. Understanding the evolution of HRSV is vital for developing strategies for its control.

Identifiants

pubmed: 38596821
doi: 10.1016/j.ijregi.2024.03.009
pii: S2772-7076(24)00025-0
pmc: PMC11002793
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100354

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Auteurs

Paul Simusika (P)

Tohoku University Graduate School of Medicine, Department of Virology, Sendai, Japan.
University Teaching Hospitals, Pathology and Microbiology Department, Virology Laboratory, Lusaka, Zambia.
Levy Mwanawasa Medical University, Institute of Basic and Biomedical Sciences ,Lusaka, Zambia.

Michiko Okamoto (M)

Tohoku University Graduate School of Medicine, Department of Virology, Sendai, Japan.

Clyde Dapat (C)

Tohoku University Graduate School of Medicine, Department of Virology, Sendai, Japan.

Walter Muleya (W)

University of Zambia, School of Veterinary Medicine, Department of Biomedical Sciences, Lusaka, Zambia.

Moffat Malisheni (M)

University Teaching Hospitals, Pathology and Microbiology Department, Virology Laboratory, Lusaka, Zambia.

Sikandar Azam (S)

Tohoku University Graduate School of Medicine, Department of Virology, Sendai, Japan.

Takeaki Imamura (T)

Tohoku University Graduate School of Medicine, Department of Virology, Sendai, Japan.

Mayuko Saito (M)

Tohoku University Graduate School of Medicine, Department of Virology, Sendai, Japan.

Innocent Mwape (I)

Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Evans Mpabalwani (E)

University of Zambia, School of Medicine, Department of Pediatrics and Child Health, Lusaka, Zambia.

Mwaka Monze (M)

University Teaching Hospitals, Pathology and Microbiology Department, Virology Laboratory, Lusaka, Zambia.

Hitoshi Oshitani (H)

Tohoku University Graduate School of Medicine, Department of Virology, Sendai, Japan.

Classifications MeSH